Genomics Middle East (GenoME) Conference will come to the UAE for the First Time in October to Shape the Future of Personalized Medicine

DUBAI and ABU DHABI, United Arab Emirates, May 19, 2016 /PRNewswire/ — For the first time ever, the Genomics Middle East (GenoME) Conference to the UAE on 31 October after its successful launch in Saudi Arabia earlier in May.

GenoME seeks to empower patients and doctors with extremely powerful genetic information that now can be more affordably unlocked. Currently, researchers are taking the potential of the genome and translating it into medical progress.

Personal variations in the human genome can determine the risk of cancer, genetic disease and the efficacy of medication, pointing to huge untapped potential in the prevention, management and curing of diseases.

To enable this transformation, researchers, clinicians and technologists need collaborative and computing platforms to share knowledge and to speed genome sequencing.

GenoME, organized by HIMSS Middle East, launched a powerful international event that gathered opinion leaders and international solution providers Intel, EMC and Alliance Global in May. Come October, HIMSS will once again gather stakeholders and researchers to bring forward the latest in biomarkers and signatures that lead the way to isolating disease in its earliest stages. Innovators will capture the latest research and discuss how the industry can continue to drive down the average cost per genome. Clinicians will focus on translating the incredible complexity of genomics into practical applications in healthcare.

Topics discussed include accelerating deployment of genomics research in the UAE, setting up big data systems for life sciences, big data analytics, big data precision medicine and more.

With the UAE healthcare market expected to grow by 7% from 2015 to 2020, propelled by medical tourism, demand for technologies and personalized medicine will exponentially increase. GenoME will be the invaluable opportunity to network with the best minds, the most influential decision makers and shape the very real future of personalized medicine.

Visit for more information.